Accueil › Cancer du poumon › Tennessee › Memphis
Essais cliniques pour Cancer du poumon à Memphis, TN
18 études pour Cancer du poumon recherchent des participants dans et autour de Memphis (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Recrutement en coursPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Recrutement en coursPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Recrutement en coursPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Recrutement en coursPhase 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Recrutement en coursPhase 2
- Research Site, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Baptist Cancer Center, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Recrutement en coursPhase 3
- Baptist Memorial Hospital-Memphis, Memphis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Recrutement en coursPhase 3
- Baptist Cancer Center, Southaven · à 11 mi
- West Cancer Center & Research Institute, Germantown · à 14 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Recrutement en coursPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Recrutement en coursPhase 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Recrutement en coursPhase 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Recrutement en coursPhase 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recrutement en coursPhase 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · à 12 mi
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · à 23 mi
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Recrutement en coursVolontaires sains bienvenus
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Memphis
Essais pour Cancer du poumon dans d'autres villes
- Houston, TX78 études
- Boston, MA62 études
- New York City, NY60 études
- Los Angeles, CA45 études
- Washington, DC41 études
- Arlington, VA41 études
- Chicago, IL41 études
- Nashville, TN40 études
- Baltimore, MD40 études
- St. Louis, MO39 études
- Columbus, OH37 études
- Philadelphia, PA36 études
Autres études à Memphis
- Cancer (tous types)31 études
- Cancer du poumon non à petites cellules23 études
- Cancer du sein22 études
- Drépanocytose18 études
- Leucémie aiguë lymphoblastique16 études
- Leucémie aiguë myéloïde15 études
- Insuffisance cardiaque13 études
- Cancer colorectal11 études
- Sarcome des tissus mous11 études
- Mélanome11 études
- Cancer de la prostate11 études
- Ostéosarcome10 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.